SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000873303-14-000018
Filing Date
2014-03-04
Accepted
2014-03-04 20:11:12
Documents
1
Period of Report
2014-02-28

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgardoc.html 4  
1 PRIMARY DOCUMENT edgardoc.xml 4 5975
  Complete submission text file 0000873303-14-000018.txt   7613
Mailing Address 215 FIRST STREET SUITE 7 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 7 CAMBRIDGE MA 02142 857-242-3700
Sarepta Therapeutics, Inc. (Issuer) CIK: 0000873303 (see all company filings)

IRS No.: 930797222 | State of Incorp.: MA | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 3450 MONTE VILLA PARKWAY BOTHELL WA 98011
Business Address
Kaye Edward M. MD (Reporting) CIK: 0001522780 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-14895 | Film No.: 14667047